Research on new antimalarial drugs and the use of drugs in combination at the Bangkok Hospital for tropical diseases

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 29, Issue 2, 1998, Pages 344-354

  Looareesuwan, Sornchai ^a   Wilairatana, Polrat ^a   Chokejindachai, Watcharee ^a   Viriyavejakul, Parnpen ^a   Krudsood, Srivicha ^a   Singhasivanon, Pratap ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT;

DRUG COMBINATION; HUMAN; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; REVIEW; THAILAND;

ANTIMALARIALS; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; HUMANS; MALARIA, FALCIPARUM; THAILAND;

EID: 0032082213     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Barradell LB, Fitton A. Artesunate: A review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs 1995;50:714-41.
2. Brewer TG, Grate SJ, Peggins JQ, et al. Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 1994a; 51: 251-9.
3. Brewer TG, Peggins JO, Grate SJ, et al. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg 1994b; 88 (suppl 1) : 33-6.
4. Bunnag D, Harinasuta T. The current status of drug resistant malaria. Int J Parasitol 1987a; 17:169-80.
5. Bunnag D, Harinasuta T, Vanijanonta S, et al. Treatment of chloroquine-resistant falciparum malaria with a combination of quinine, quinidine and cinchonine (LA 40221) in adults by oral and intravenous administration. Acta Leidensia 1987b; 55: 139-49.
6. Bunnag D, Harinasuta T, Looareesuwan S, et al. A combination of quinine, quinidine and cinchonine (LA 40221) in the treatment of chloroquine resistant falciparum malaria in Thailand: two double-blind trials. Trans R Soc Trop Med Hyg 1989; 83:66.
7. Bunnag D, Viravan C, Looareesuwan S, et al. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand: a preliminary report. Southeast Asian J Trop Med Public Health 1991a; 22: 380-5.
8. Bunnag D, Viravan C, Looareesuwan S, et al. Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria. Southeast Asian J Trop Med Public Health 1991b; 22: 534-8.
9. Bunnag D, Viravan C, Looareesuwan S, et al. Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria. Southeast Asian J Trop Med Public Health 1991c; 22: 539-43.
10. Bunnag D, Viravan C, Karbwang J, et al. Clinical trials with halofantrine in acute uncomplicated falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health 1993; 24: 43-5.
11. Chawira AN, Warhurst DC. The effect of artemisinin combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. Am J Trop Med Hyg 1987a; 90: 1-8.
12. Chawira AN, Warhurst DC, Robinson BL, et al. The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment in mice. Trans R Soc Trop Med Hyg 1987b; 81: 554-8.
13. Chongsuphajaisiddhi T, Sabchareon A. Sulfadoxine-pyrimethamine resistant falciparum malaria in Thai children. Southeast Asian J Trop Med Public Health 1981a; 12: 418-21.
14. Chongsuphajaisiddhi T, Sabcharoen A, Attanath P, et al. In vitro and in vitro sensitivity of falciparum malaria to quinine in Thai children. Ann Trop Paediatr 1981b; 1: 21-6.
15. Chongsuphajaisiddhi T, Sabchareon A, Attanath P, et al. Treatment of quinine resistant falciparum malaria in Thai children. Southeast Asian J Trop Med Public Health 1983; 15: 357-2.
16. Colwell EJ, Hickman RL, Kosakal S, et al. Tetracycline treatment of chloroquine- resistance falciparum malaria in Thailand. JAMA 1972; 220: 684-6.
17. Colwell EJ, Hickman RL, Kosakal S, et al. Quinine-tetracycline and quinine-bactrim treatment of acute falciparum malaria in Thailand. Ann Trop Med Parasitol 1973; 67: 125-32.
18. Druilhe P, Brandicourt O, Chongsuphajaisiddhi T, et al. Activity of a combination of three cinchona alka-loids against Plasmodium falciparum in vitro. Anti-microbial Agents Chemotherapy 1988; 32: 250-4.
19. Field JW, Niven JC. A note on prognosis in relation to parasite counts in acute subterian malaria. Trans R Soc Trop Med Hyg 1937; 30: 569-74.
20. Geary TG, Jensen JB. Effects of antibiotics on Plasmodium falciparum in vitro. Am J Trop Med Hyg 1983; 32: 221-5.
21. Gershon PD, Howells RE. Combination of the antibiotics erythromycin and tetracycline with three standard antimalarials against Plasmodium falciparum in vitro. Ann Trop Med Parasitol 1984; 78: 1-11.
22. Green RA. Totaquine in the treatment of malaria. Bull US Army Medical Department 1945; 51: 40.
23. Guo X, Fu L, Fan T. Thirty-three patients with cerebral malaria treated with intravenous artesunate. In: Li G, Guo X, Fu Y, eds. Clinical Trials on Qinghaosu and its derivatives (vol 1). Guangzhou: Guangzhou College of Traditional Chinese Medicine, Sanya Tropical Medicine Institute, 1990: 59-63.
24. Hall AP, Doberstyn EB, Karnchanachetanee C, et al. Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria. Br Med J 1977; 1: 1626-8.
25. Harinasuta T, Viravan C, Reid, HA, et al. Sulphamethoxine in chloroquine-resistant falciparum malaria in Thailand. Lancet 1967; 1: 1117.
26. Harinasuta T, Bunnag D, Vanijanonta S,et al. Mefloquine, sulfadoxine, and pyrimethamine in treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose. Bull WHO 1987; 65: 363-7.
27. Hien TT, Arnold K, Vinh H, et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg 1992a; 86: 582-3.
28. Hien TT, Phu NH, Mai NT, et al. An open randomized comparison of intravenous and intramuscular artesunate in severe falciparum malaria. Trans R Soc Trop Med Hyg 1992b; 86: 584-5.
29. Hien TT, White NJ. Qinghaosu. Lancet 1993; 341: 603-8.
30. Hien TT, Day NP, Nguyen HP, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996; 335: 76-83.
31. Kaddu JB, Warhurst DC, Peters W, et al. The activity of a tetracycline derivative, minocycline, on Plasmodium berghei. Ann Trop Med Parasitol 1974; 68: 41-6.
32. Karbwang J, Molunto P, Bunnag D, et al. Plasma quinine levels in patients with falciparum malaria when given alone or in combination with tetracycline with or without primaquine. Southeast Asian J Trop Med Public Health 1990; 22: 72-6.
33. Karbwang J, Tin T, Rimchala W, et al. Comparison of artemether and quinine in the treatment of severe falciparum malaria in southeast Thailand. Trans R Soc Trop Med Hyg 1995; 89: 668-71.
34. Klayman DL. Qinghaosu (Artemisinin): an antimalarial drug from China. Science 1985; 228: 1049-55.
35. Li GQ, Guo XB, Jin R, et al. Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives. J Tradit Chin Med 1982; 2: 125.
36. Li GQ, Guo XB, Fu LC, et al. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans R Soc Trop Med Hyg 1994; 88 (suppl 1): 5-6.
37. Looareesuwan S, Phillips RB, White NJ, et al. Intravenous amodiaquine and oral amodiaquine-erythromycin in the treatment of chloroquine- resistant falciparum malaria. Lancet 1985; 2: 805-8.
38. Looareesuwan S, Charoenlarp P, Ho M, et al. Fatal Plasmodium falciparum malaria after an inadequate response to quinine treatment. J Infect Dis 1990; 161: 577-80.
39. Looareesuwan S, Harinasuta T, Chongsuphajaisiddhi T. Drug resistant malaria with special reference to Thailand. Southeast Asian J Trop Med Public Health 1992a; 23: 621-34.
40. Looareesuwan S, Viravan C, Vanijanonta S, et al. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 1992b; 339: 821-4.
41. Looareesuwan S, Kyle DE, Viravan C, et al. Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine. Am J Trop Med Hyg 1992c;47:794-9.
42. Looareesuwan S, Wilairatana P, Vanijanonta S, et al. Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand. Lancet 1992d; 1: 369.
43. Looareesuwan S, Viravan S, Vanijanonta S, et al. Treatment of acute uncomplicated falciparum malaria with a short course of artesunate followed by mefloquine. Southeast Asian J Trop Med Public Health 1993; 24: 230-4.
44. Looareesuwan S, Vanijanonta S, Viravan C, et al. Randomized trial of mefloquine alone and artesunate followed by mefloquine for the treatment of acute uncomplicated falciparum malaria. Ann Trop Med Parasitol 1994a; 88: 131-6.
45. Looareesuwan S, Vanijanonta S, Viravan C, et al. Randomised trial of mefloquine-tetracycline, and quinine-tetracycline for acute uncomplicated falciparum malaria. Acta Tropica 1994b; 57: 47-53.
46. Looareesuwan S, Viravan C, Vanijanonta S, et al. Randomized trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria. Am J Trop Med Hyg 1994c; 50: 784-9.
47. Looareesuwan S. Overview of clinical studies on artemisinin derivatives in Thailand. Trans R Soc Trop Med Hyg 1994d; 88(suppl 1): 9-11.
48. Looareesuwan S, Wilairatana P, Vanijanonta S, et al. Efficacy and tolerability of a sequential, artesunate suppository plus mefloquine, treatment of severe falciparum malaria. Ann Trop Med Parasitol 1995; 89: 469-75.
49. Looareesuwan S, Wilairatana P, Vanijanonta S, et al. Treatment of acute uncomplicated falciparum malaria with oral dihydroartemisinin. Ann Trop Med Parasitol 1996a; 90: 21-8.
50. Looareesuwan S, Kyle DE, Viravan C, et al. Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Am J Trop Med Hyg 1996b; 54: 205-9.
51. Looareesuwan S, Viravan C, Vanijanonta S, et al. Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria : two and three-day regimens. Am J Trop Med Hyg 1996c; 54:210-13.
52. Looareesuwan S, Olliaro P, Kyle D, et al. Pyronaridine. Lancet 1996d; 347: 1189-90.
53. Looareesuwan S, Viravan C, Webster HK, et al. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 1996e; 54: 62-6.
54. Looareesuwan S, Wilairatana P, Vanijanonta S, et al. A comparative clinical trial of sequential treatments of severe malaria with artesunate suppository followed by mefloquine in Thailand. Am J Trop Med Hyg 1997a; 57: 348-53.
55. Looareesuwan S, Wilairatana P, Viravan C, et al. Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria. Am J Trop Med Hyg 1997b; 56: 613-7.
56. Looareesuwan S, Wilairatana P, Gemperli B, et al. Phase III trial in Thailand comparing a new oral combination antimalarial CGP 5669 with oral mefloquine in the treatment of Plasmodium falciparum malaria. Am J Trop Med Hyg 1997c (in press).
57. Merkli B, Richle RW. Studies on the resistance to single and combined antimalarials in the Plasmodium berghei mouse model. Acta Tropica 1980a; 37: 228-31.
58. Merkli B, Richle RW, Peters W, et al. The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei. Ann Trop Med Parasitai 1980b; 74: 1-9.
59. Nocht B, Werner H. Beobachtungen über relative Chininresistenz bei Malaria aus Brasilien. Deutsche Medizinische Wochenscrift 1910; 36: 1557-60.
60. Noeypatimanond S, Malikul S, Benjapong W, et al. Treatment of Plasmodium falciparum malaria with a combination of amodiaquine and tetracycline in Central Thailand. Trans R Soc Trop Med Hyg 1983; 77: 338-40.
61. Nosten F, Imvithaya S, Vincenti M, et al. Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine- pyrimethamine. Bull WHO 1987; 65: 891-6.
62. Nosten F, ter Kuile F, Luxemburger, et al. Cardiac effects of antimalarial treatment with halofantrine. Lancet 1993; 341: 1054-6.
63. Pang LW, Bovdreua EF, Childs GE, et al. Failure of large-dose erythromycin in combination with a standard dose of chloroquine or quinine in the treatment of human falciparum malaria. Bull WHO 1985; 63: 739-43.
64. Peters W. Prevention of drug resistance in rodent malaria y the use of drug mixtures. Bull WHO 1974; 51: 379-83.
65. Phillips Howard PA, ter Kuile FO, et al. CNS adverse events associated with antimalarial agents. Fact or fiction? Drug Safe 1995; 12: 370-83.
66. Phillips RE, Looareesuwan S, Karbwang J, et al. Failure of chloroquine-erythromycin combinations in treatment of chloroquine- resistant falciparum malaria in eastern Thailand. Lancet 1984; 1: 300-2.
67. Price RN, Nosten F, Luxemburger C, et al. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg 1995; 89: 523-7.
68. Pukrittayakamee S, Supanaranond W, Looareesuwan S, et al. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg 1994; 88: 324-7.
69. Puri SK, Dutta GP. Antibiotics in the chemotherapy of malaria. Prog Drug Res 1982; 26: 167-202.
70. Rahman NA, Warhurst DC. Drug synergism against Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 1985; 79: 279.
71. Reacher M, Campbell CC, Freeman J, et al. Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine sulfadoxine (Fansidar®). Lancet 1981;2:1066-8.
72. Taylor TE, Wills BA, Kazembe P, et al. Rapid coma resolution with artemether in Malawian children with cerebral malaria. Lancet 1983; 341: 661-2.
73. Ter Kuile FO, Dolan G, Nosten F, et al. Halofontrine versus mefloquine in the treatment of multidrug resistant falciparum malaria. Lancet 1993; 341: 1044-9.
74. Thimasarn K, Pinichpongse S, Malikul S, et al. Phase III double-blind comparative study of Fansimef® and Lariam® for the curative treatment of Plasmodium falciparum infections in Thailand. Southeast Asian J Trop Med Public Health 1990; 21: 404-11.
75. van Hensbroek MB, Onyiorah E, Jaffar S, et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996; 335: 69-75.
76. van Vugt M, Brockman A, Gemperli B, et al. A randomised comparison of artemether-benflumetol and artesunate-mefloquine in the treatment of multidrug resistant falciparum malaria. Antimicrob Agents Chemother 1997 (in press).
77. Warhurst DC, Robinson BL, Peters W, et al. The chemotherapy of rodent malaria XXIV. The blood schizontocidal action of erythromycin upon Plasmodium berghei. Ann Trop Med Parasitai 1976; 70: 253-8.
78. Warhurst DC, Homewood CA, Peters W, et al. The blood schizontocidal action of erythromycin against Plasmodium knowlesi infections in Macaca mulatta. Ann Trop Med Parasitol 1983; 77: 231-37.
79. Wesche DL, DeCoster MA, Tortella FC, et al. Neurotoxicity of artemisinin analogs in vitro. Antimicrob Agents Chemother 1994; 38: 1813-9.
80. White NJ, Looareesuwan S, Warrell DA, et al. Quinine loading dose in cerebral malaria. Am J Trop Med Hyg 1983; 32: 1-5.
81. White NJ. Artemisinin: current status. Trans R Soc Trop Med Hyg 1994a; 88 (suppl 1):3-4.
82. White NJ. Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives. Trans R Soc Trop Med Hyg 1994b; 88 (suppl 1): 41-3.
83. Wilairatana P, Looareesuwan S. APACHE II scoring for predicting outcome in cerebral malaria. J Trop Med Hyg 1995; 98: 256-60.
84. Wilairatana P, Kyle DE, Looareesuwan S, et al. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute uncomplicated falciparum malaria in Thailand. Ann Trop Med Parasitol 1997 (in press).
85. Win K, Than M, Thwe Y, et al. Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria. Bull WHO 1992; 70: 777-82.
86. World Health Organization. Advances in malaria chemotherapy. Report of a WHO Scientific Group. Geneva: WHO Tech Rep Ser 1984; 711: 61-3.
87. World Health Organization. The role of artemisinin and its' derivatives in the current treatment of malaria (1994-1995): Report of an informal consultation: 1993 Sep 27-29; Geneva, WHO/MAL 94.1067: 1-49.